-
Mashup Score: 1High Grade Complication Rates Seen With Post-Robotic Radical Cystectomy | GU Oncology Now - 3 day(s) ago
Robotic cystectomy after neoadjuvant immunotherapy shows higher severe complication rates than surgery alone.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2IMvigor011 Exploratory Analysis Reveals OS, DFS Rates of ctDNA-Negative Patients With MIBC | GU Oncology Now - 26 day(s) ago
IMvigor011 compared the efficacy of atezolizumab with placebo in patients with HR MIBC who remained ctDNA-positive post-cystectomy using Signatera.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet-
❇️ At #SUO24, an exploratory analysis of the phase III IMvigor011 trial’s surveillance cohort has provided new data on the DFS and OS rates of patients with HR #MIBC who have continual ctDNA-negative biomarker status after undergoing cystectomy: https://t.co/vAFWgBiIck
-
⚙️ Based on findings presented at #SUO24, patients with #MIBC who undergo robotic-assisted radical cystectomy after neoadjuvant treatment may have more higher-grade complication rates compared to patients undergoing robotic radical cystectomy alone: https://t.co/4QhbBYUqAn